Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 10/20 | 0.62 |
| ▸ | MME | P08473 | 9/20 | 0.62 |
| ▸ | CPA1 | P15085 | 3/20 | 0.62 |
| ▸ | ACE2 | Q9BYF1 | 3/20 | 0.62 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.60 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27935801 | 1.00 | ACE (0.62) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL27704335 | 1.00 | ACE (0.62) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL4273365 | 1.00 | ACE (0.62) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL27704333 | 1.00 | ACE (0.62) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL4273366 | 1.00 | ACE (0.62) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL29822661 | 0.97 | MME (0.60) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL30577827 | 0.95 | ACE (0.57) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL29351001 | 0.94 | ACE (0.61) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL31753582 | 0.94 | ACE (0.56) | ACEMMECPA1ACE2FOLH1 | |
| SCHEMBL32679640 | 0.92 | FOLH1 (0.67) | ACEMMECPA1ACE2FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1234576-C | packaging and painting unit | OREAL (FR) | 2006-01-04 | — | — | CN | disclosed |
| US-6945723-B1 | Packaging and application device | L'ORÉAL (FR) | 2005-09-20 | — | — | US | disclosed |
| CN-1162308-C | Assembly of packing and using liquid-powder | �ź㴫 | 2004-08-18 | — | — | CN | disclosed |
| US-6682244-B2 | Devices and methods for dispensing | L'OREAL S.A. (FR) | 2004-01-27 | — | — | US | disclosed |
| US-20020041854-A1 | Cosmetic compositions in powder form comprising a binder, and make-up and cosmetic care methods | L'OREAL S.A. (FR) | 2002-04-11 | — | — | US | disclosed |
| US-20020034480-A1 | Make-up compositions comprising a binder phase, and make-up methods | L'OREAL, S.A. (FR) | 2002-03-21 | — | — | US | disclosed |
| US-20020021932-A1 | Devices and methods for dispensing | L'OREAL S.A. (FR) | 2002-02-21 | — | — | US | disclosed |
| CN-1324749-A | Assembly of packing and using liquid-powder | OREAL (FR) | 2001-12-05 | — | — | CN | disclosed |
| CN-1290641-A | packaging and painting unit | OREAL (FR) | 2001-04-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020034480-A1 | Make-up compositions comprising a binder phase, and make-up methods | TTR, GRN, MB | ACE 1352/4885MME 3606/4885CPA1 3671/4885 |
| US-20020041854-A1 | Cosmetic compositions in powder form comprising a binder, and make-up and cosmetic care methods | CUTA, LAGE3, MITF | ACE 3485/4885MME 4307/4885CPA1 4109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.